STAT+: Tracking the FDA expert review of Replimune’s melanoma treatment
STAT News · LC · trust 49/100
STAT is live-blogging a meeting of FDA experts to review Replimune’s experimental melanoma drug, RP1.
Read the original at STAT News →
Open in TruthVane →